Emodin suppresses hyperglycemia-induced proliferation and fibronectin expression in mesangial cells via inhibiting cFLIP.
As one of the most serious microvascular complications of diabetes and a major cause of end stage renal disease, diabetic nephropathy (DN) is calling for effective treatment strategies. Here, we provide evidence that hyperglycemia can induce proliferation and decreasing apoptosis of mesangial cells...
Main Authors: | Junjie Gao, Fangli Wang, Weisong Wang, Zhiguo Su, Canghui Guo, Shuyi Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3972111?pdf=render |
Similar Items
-
FLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIP
by: Yuichi Tsuchiya, et al.
Published: (2015-12-01) -
cFLIP expression is altered in severe corticosteroid-resistant asthma
by: Dennis Lazarev, et al.
Published: (2014-12-01) -
Protective Roles for Caspase-8 and cFLIP in Adult Homeostasis
by: Ricardo Weinlich, et al.
Published: (2013-10-01) -
Targeting cFLIP to inhibit residual cancer stem cells after chemotherapy
by: Robinson, Timothy
Published: (2017) -
Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ERα Inhibition
by: Pao-Hsuan Huang, et al.
Published: (2013-01-01)